Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues		$ 0	$ 281
Operating expenses:
Research and development		2,726	2,843
General and administrative		3,680	3,924
Total operating expenses		6,406	6,767
Loss from operations		(6,406)	(6,486)
Other (expense) income:
Interest income		48	54
Interest expense		(42)	(23)
Change in fair value of rights from Private Placement		(3,832)	0
Change in fair value measurement of notes payable		(9)	(6)
Other income (expense), net		(8)	(19)
Total other (expense) income, net		(3,843)	6
Net loss		(10,249)	(6,480)
Net loss attributable to noncontrolling interest		(11)	(29)
Net loss attributable to Kineta, Inc.		$ (10,238)	$ (6,451)
Net loss per share, basic		$ (0.89)	$ (0.77)
Net loss per share, diluted		$ (0.89)	$ (0.77)
Weighted-average shares outstanding, basic	[1]	11,443	8,361
Weighted-average shares outstanding, diluted	[1]	11,443	8,361
Collaboration revenue [Member]
Revenues:
Total revenues		$ 0	$ 281

[1] Included in the denominator were 663,000 weighted-average shares of common stock warrants for the three months ended March 31, 2024, with an exercise price of $0.14. Included in the denominator were 520,000 weighted-average shares of common stock warrants for the three months ended March 31, 2023, with an exercise price of $0.14.